Thus, 5-FU enhances tumor inhibition when combined with the other agents but does not interfere with the inhibition of oncogenic signaling by PEPDG278D and does not interfere with aderbasib inhibition of EGFR ligand shedding by tumor cells. This evidence concerns the gene EGFR and neoplasm.